RxDoctor Payments DataLook up a doctor →

Mudassar Ahmed

Interventional Cardiology · Gainesville, GANPI 1366595324

Payments from drug & device makers

$765,091in general payments, 2019–2025

Across 557 payments — averaging $1373.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$493K
  • Edwards Lifesciences$179K
  • CSL Behring$54K
  • Medtronic$21K
  • Daiichi Sankyo Inc.$16K
  • Abbott$1K
  • plus $932 from 7 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$765,091 in reported general payments places this provider in the 90th percentile of 218 interventional cardiology providers in Georgia.

See all interventional cardiology providers in Georgia

Medicare billing

Part B allowed, 2024
$36,057
Medicare patients
128
Services billed
504

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Gainesville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →